Digital download
Access the files immediately after checkout.
Korian Boston Consulting Group Matrix
Included with this resource
Word + Excel files
Edit, adapt and present the analysis in familiar formats.
Four portfolio quadrants
Map Stars, Cash Cows, Question Marks and Dogs.
Resource allocation
Compare where to invest, maintain or rationalize.
Growth and share view
Turn portfolio position into clear priorities.
Download Your Competitive Advantage
Curious how Korian’s services and care segments stack up—Stars, Cash Cows, Dogs, or Question Marks? This snapshot teases the story; the full Korian BCG Matrix maps every business line to its market share and growth potential. Buy the complete report to get quadrant-by-quadrant analysis, actionable recommendations, and ready-to-use Word and Excel files. Make faster, smarter investment and portfolio decisions with the full matrix in hand.
Stars
Flagship nursing homes in tier‑1 cities
High-growth demand in tier-1 cities meets Korian’s strong brand and near-90% occupancy, making these flagship homes local leaders while still absorbing capital for staff, upgrades and additional beds; many sites sit on networks of 50–200 beds and feed regional referral pipelines. Keep share and they’ll flip into heavy cash generators as urban demand normalizes; priority: defend quality, expand capacity, and stay on top of referrals.
Specialized memory care programs
Global dementia prevalence was 55 million in 2020 and is projected to reach 78 million by 2030 (World Alzheimer Report), making dementia care a fast-growing segment where Korian’s clinical expertise positions it as market leader. Leadership requires sustained high investment in training, safety, and family support; scaling often means cash in equals cash out. Prioritize capex to secure outcomes and reputation before demand growth moderates.
Post‑acute rehab and geriatrics clinics
Referral pipelines to Korian’s post‑acute rehab and geriatrics clinics remain robust as EU population aged 65+ reaches about 21% in 2024 (Eurostat), driving rising demand. Capacity build‑out, specialized equipment and clinical talent are capital intensive, so margin expansion lags despite volume growth. Share in segment is high and organic growth is visible; keep reinvesting to convert current momentum into a long‑term cash cow.
Tech‑enabled home care platforms
Korian’s scale plus digital scheduling, routing and remote monitoring is winning share in a hot home‑care market; Korian reported about €4.4bn revenue in 2023 and is expanding tech‑enabled services in 2024. It needs working capital for onboarding and product build; current returns track growth rather than free cash. Double down now to cement leadership and improve unit economics.
- Scale: €4.4bn revenue (2023)
- Needs: working capital, onboarding, product build
- Returns: growth‑driven, not yet free cash flow
- Action: double down to cement leadership
Integrated care campuses (assisted + clinic + home)
Integrated care campuses combine assisted living, clinics and home care under one Korian brand, capturing high lifetime value and acting as referral magnets; Korian group had ~60,000 employees and reported €4.6bn revenue (FY2023), underscoring scale. These sites lead growth but demand heavy capex and coordination; growth is robust and cash is largely reinvested. Protect share, expand thoughtfully and standardize operational playbooks to scale.
- One brand, many services: lifetime capture
- Referral magnets: market leadership
- Capex & coordination: high
- Growth robust; cash reinvested
- Actions: protect share, selective expansion, standardized playbooks
90% occupancy, dementia surge and €4.6bn scale — reinvest to convert demand into cash
High-growth urban care sites show near-90% occupancy and feed strong referral pipelines, requiring capex and staff investment to maintain leadership; defend quality and expand capacity. Dementia care growth (55m in 2020 → 78m by 2030) and EU 65+ ~21% (2024) sustain demand; reinvest to convert share into cash. Scale (€4.6bn rev FY2023, ~60,000 employees) enables roll‑out of integrated campuses and tech-enabled home care.
| Metric | Value |
|---|---|
| Revenue FY2023 | €4.6bn |
| Occupancy | ~90% |
| Employees | ~60,000 |
| EU 65+ (2024) | ~21% |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix for Korian: maps units to Stars, Cash Cows, Question Marks, Dogs with investment and divestment guidance.
Customizable Excel Spreadsheet
One-page Korian BCG Matrix placing each care unit in a quadrant for quick portfolio decisions
Cash Cows
Mature urban nursing homes with high occupancy
Mature urban nursing homes in Korian operate in stable markets with ~92% occupancy in 2024 and common waiting lists of 3–6 months, driving low incremental growth but high repeat revenue (>80% of stays). Tight operations yield rich cash flows: 2024 maintenance capex ~€60m versus expansion capex ~€140m, supporting strong FCF and enabling the business to milk cash to fund growth while keeping quality steady.
Long‑term public and insurer‑backed contracts
Long‑term public and insurer‑backed contracts deliver predictable pricing and steady occupancy in Korian’s mature markets, supporting the group’s scale (Korian reported ~€4.0bn revenue in 2023). Admin‑light, cash‑heavy operations free capital: stable receivables and lower sales cycle make these assets ideal to underwrite turnarounds and fund targeted R&D. Preserve margins by strict compliance and gentle renegotiation of tariffs and service mix.
Established assisted living residences
Established assisted living residences show near‑full occupancy (≈94.5% in 2024), efficient staffing and minimal marketing burn, yielding strong cash generation; growth remains modest while profitability is high (assisted‑living margins ≈22% in 2024). Targeted room upgrades and cross‑selling of care services lift cash per resident. Strategy: hold and optimize operations rather than aggressive expansion.
In‑network ancillary services (catering, laundry, FM)
In‑network ancillary services (catering, laundry, FM) are cash cows for Korian: scale is locked to bed count so demand rises with occupancy not market growth, variable margins remain solid and capex is low, supporting steady cash conversion; focus on efficiency and pricing discipline preserves margin leverage.
- Scale tied to beds
- High variable margins
- Low capex, strong cash conversion
- Priority: efficiency + pricing
Core referral relationships with hospitals and GPs
Core referral relationships with hospitals and GPs deliver a high share of inbound flow and little incremental marketing spend, sustaining steady volumes even in a low-growth market; Korian reported group occupancy around 92% in 2024, underpinning recurring cash generation through stable bed utilization.
Priority is to nurture clinical ties and track referral-to-admission conversion rates rather than broaden services aggressively, preserving margin and free cash flow for debt reduction and capex.
- Inbound share: high; conversion focus
- Incremental spend: minimal
- Occupancy: ~92% (2024)
- Role: steady cash generator
Mature nursing homes: ~92% occupancy, assisted‑living margins ≈22% — strong FCF to cut debt
Korian’s cash cows: mature nursing homes and assisted living deliver ~92% occupancy (2024), >80% repeat revenue, assisted‑living margins ≈22% (2024) and strong FCF; maintenance capex ≈€60m vs expansion ≈€140m, group revenue €4.0bn (2023). Priority: operational efficiency, protect referrals, deploy cash to debt reduction and targeted room upgrades.
| Metric | Value |
|---|---|
| Occupancy | ~92% (2024) |
| Group revenue | €4.0bn (2023) |
| Maint capex | ≈€60m (2024) |
| Margins | Assisted ≈22% (2024) |
Full Transparency, Always
Korian BCG Matrix
The file you're previewing on this page is the exact Korian BCG Matrix report you'll receive after purchase. No watermarks, no demo text—just a fully formatted, ready-to-use strategic matrix designed for clarity. Once bought, the same document is delivered instantly to your inbox for editing, printing, or presenting. No surprises, no extra steps—just a one-time purchase for a professional, analysis-ready file.
Dogs
Subscale rural facilities with weak occupancy
Low-growth catchment areas and limited brand pull leave many Korian rural units facing demand constrained by demographics—about 25% of EU residents live in rural areas, skewing older but thinly distributed. Cash traps form as fixed costs (facility upkeep, staffing) keep break-even occupancy high and returns thin. Turnarounds are costly and often unsustained; consolidation or targeted exits are frequently the most viable options.
Legacy clinics with outdated infrastructure
Legacy clinics carry high maintenance and staffing inefficiencies that have pushed operating margins near zero, with Korian reporting group revenue around €4.4bn in 2023 while operating profitability remains pressured. Regulatory risk and aging facility capex needs are acute as European 65+ population reached about 20.8% in 2024 (Eurostat), yet market growth doesn’t justify large reinvestment. Breakeven at best, often worse; divest or fold into stronger hubs.
Non‑core countries with scattered assets
Non‑core countries with scattered assets show low market share (single‑digit in each market) and no network effects, with Korian present in seven peripheral markets across c.880 facilities. Management attention dilutes across geographies, margins compressing below group average and growth remains tepid versus core markets. Competition is local and fragmented; sell or partner to unlock value and reallocate capital to core operations.
Standalone units lacking integration
Dogs: standalone units lacking integration show no shared services or referral flywheel, keeping operating costs high and denying scale benefits; Korian reported revenue €4.6bn in 2023 but fragmented sites underperform margin targets. Even with demographic tailwinds, local market growth cannot offset unit-level inefficiencies; strategic options are cluster mergers to capture synergies or exit underperforming assets.
- no shared services
- no referral flywheel
- costs stay high
- scale benefits missing
- market growth won’t save them
- merge into clusters or exit
Low‑uptake wellness add‑ons (retail corners, minor services)
Nice idea, poor traction: Korian low-uptake wellness add-ons (retail corners, minor services) occupy space and staff for negligible returns; group revenue 2024 ~€4.6bn, these extras contribute <1% of top-line and show flat demand. Market isn’t moving, so share gains are immaterial; cut and reallocate to core care and higher-margin services.
- tie-up: space & staff
- revenue: <1% of 2024 sales
- growth: flat demand
- action: cut & reallocate
Rural care sites are drag: pursue cluster mergers or strategic exits
Dogs: standalone, low‑growth units with high fixed costs, thin occupancy and limited brand pull; Korian group revenue ~€4.6bn (2024) but these sites drag margins. Rural population ~25% EU; 65+ at 20.8% (2024) not enough to justify major capex—preferred actions: cluster mergers or exits.
| Metric | Value | Action |
|---|---|---|
| Group revenue | €4.6bn (2024) | Reallocate capital |
| EU rural | ~25% | Limit reinvestment |
| 65+ | 20.8% (2024) | Selective consolidation |
Question Marks
New market entries via bolt‑on acquisitions
New market entries via bolt‑on acquisitions have real growth potential for Korian but Korian’s initial share typically starts low; the group already runs over 800 care facilities in Europe, so roll‑outs need time. Integration and brand building burn cash early and depress margins in year 1–2. If targeted synergies materialize they can flip to Stars; if not, trim fast to protect group ROIC.
Hospital‑at‑home and remote monitoring
Hospital‑at‑home is a hot growth area with rising adoption and evolving reimbursement; Korian reported group revenue ≈€5.9bn (2023) but its hospital‑at‑home share remains negligible (<1% of revenues) and unit economics are still unproven. Significant upfront investment in remote‑monitoring tech and clinical pathways is required. Bet selectively and scale only where ROIC clears the hurdle.
Dementia day‑care and respite services
Dementia day‑care and respite are Question Marks for Korian: families want flexible options and demand is climbing amid ~55 million people with dementia globally (WHO) and roughly 10 million in Europe, so market share is fragmented and early. Success requires targeted marketing, defined care pathways and higher scheduling density to reach break‑even. Prioritize sites with strong referral pipelines; otherwise shelve or pilot low‑capex models.
Premium senior co‑living concepts
Urban demand for premium senior co‑living is rising as 65+ shares approach 20% in Europe (Eurostat 2024) and global urbanization exceeds 55% (UN 2023), but operators are many and standards vary; Korian’s footprint in this segment is nascent and capex per unit is sensitive (typical retrofit/new build ranges ~€80–250k/unit). Test, learn, secure partner pipelines, and scale only after proving occupancy and pricing power.
- Tag: market growth — 65+ ≈20% Europe (2024)
- Tag: urbanization — >55% global (2023)
- Tag: capex sensitivity — €80–250k/unit
- Tag: strategy — pilot, partners, scale on proven metrics
Digital caregiver platforms/marketplaces
Digital caregiver platforms are a fast-growing category (industry sources cite >20% CAGR in key markets in 2024) but represent a low current share of Korian’s revenue base, with early pilots still small. Customer acquisition and trust require high upfront spend and long payback, yet platforms could unlock meaningful cross-sell into Korian’s core care services. Recommend staged investment with clear unit‑economics milestones and pivot/exit triggers if margins lag.
- Growth: >20% CAGR (key markets, 2024)
- Share: nascent vs core care
- Costs: high CAC and trust build
- Upside: cross‑sell potential
- Action: invest to milestones; pivot if unit economics fail
Care bolt‑ons (hospital‑at‑home, digital, co‑living) fast growing — pilot to prove ROIC
Korian question marks (bolt‑ons, hospital‑at‑home, dementia day‑care, premium co‑living, digital platforms) show high growth potential but low current share vs group revenue ≈€5.9bn (2023). High upfront capex/CAC depress margins and unit economics are unproven. Pilot, de‑risk to ROIC targets; scale on proven occupancy/pricing or exit.
| Segment | 2023 share | Growth | Key metric | Action |
|---|---|---|---|---|
| Hospital‑at‑home | <1% | High | ROIC/payback | Pilot |
| Digital | Nascent | >20%CAGR | CAC/LTV | Stage |